![James Flynn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Flynn
Director/Board Member at
LITE STRATEGY, INC.
Net worth: 111 200 $ as of 31/05/2026
Profile
James Flynn is the founder of Nerium Capital LLC, founded in 2021, serving as Managing Member & Portfolio Manager.
Current jobs include Independent Director at RiceBran Technologies since 2024, Independent Non-Executive Director at Lite Strategy, Inc. since 2023, Director at Synlogic, Inc. since 2024, and Director at Axiom Healthcare Strategies LLC since 2022.
Former jobs include Director at Axiom Health, Inc., Independent Director at ARCA biopharma, Inc., and Manager-Healthcare Portfolio at Amici Capital LLC from 2008 to 2017.
Education includes undergraduate studies at the Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LITE STRATEGY INC 0.29% | 19/12/2025 | 100,000 ( 0.29% ) | 101 000 $ | 31/05/2026 |
SYNLOGIC INC 0.13% | 31/03/2026 | 15,000 ( 0.13% ) | 10 200 $ | 31/05/2026 |
James Flynn active positions
| Companies | Position | Start |
|---|---|---|
| LITE STRATEGY, INC. | Director/Board Member | 31/10/2023 |
| RICEBRAN TECHNOLOGIES | Director/Board Member | 03/01/2024 |
| SYNLOGIC, INC. | Director/Board Member | 19/03/2024 |
Axiom Healthcare Strategies LLC
 Axiom Healthcare Strategies LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | 01/07/2022 |
Nerium Capital LLC | Founder | 01/01/2021 |
Former positions of James Flynn
| Companies | Position | End |
|---|---|---|
Amici Capital LLC
 Amici Capital LLC Investment ManagersFinance Amici Capital invests in equities both long and short. They practice a flexible, value-oriented approach that encompasses investments in the publicly traded securities of companies in a broad spectrum of industries and geographies. The firm seeks to have a core long-term, large investment in relatively few stocks on the long side, taking advantage of in-depth knowledge of favored companies, with a complement on the short side that represents both significant profit opportunities and a market hedge. Amici Capital seeks to achieve strong absolute returns in all market environments, with a concurrent focus on capital preservation. | Corporate Officer/Principal | 01/01/2017 |
| ARCA BIOPHARMA | Director/Board Member | - |
Training of James Flynn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amici Capital LLC
Amici Capital LLC Investment ManagersFinance Amici Capital invests in equities both long and short. They practice a flexible, value-oriented approach that encompasses investments in the publicly traded securities of companies in a broad spectrum of industries and geographies. The firm seeks to have a core long-term, large investment in relatively few stocks on the long side, taking advantage of in-depth knowledge of favored companies, with a complement on the short side that represents both significant profit opportunities and a market hedge. Amici Capital seeks to achieve strong absolute returns in all market environments, with a concurrent focus on capital preservation. | Finance |
RiceBran Technologies
 RiceBran Technologies Agricultural Commodities/MillingProcess Industries Engages in rice milling for producing, processing and marketing of natural and nutrient dense products derived from grains | Process Industries |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Nerium Capital LLC | |
Axiom Healthcare Strategies LLC
Axiom Healthcare Strategies LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
- Stock Market
- Insiders
- James Flynn
